Profile of elotuzumab and its potential in the treatment of multiple myeloma
Yi-Chang Liu,1,2 Susann Szmania,1 Frits van Rhee1 1Myeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences, Little Rock, AR, USA; 2Faculty of Medicine, College of Medicine, Kaohsiung Medical University and Department of Hematology-Oncology, Kaohsiung Medical Universi...
Guardado en:
Autores principales: | Liu YC, Szmania S, van Rhee F |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://doaj.org/article/f0a582c441c74bf3ba409f69f79afbc1 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Clinical potential of carfilzomib in the treatment of relapsed and refractory multiple myeloma
por: Gupta VA, et al.
Publicado: (2013) -
THE EFFECT OF BISPHOSPHONATE USE ON TREATMENT RESPONSE AND OVERALL SURVIVAL IN MULTIPLE MYELOMA PATIENTS
por: Ayşe Uysal, et al.
Publicado: (2021) -
Multiple Myeloma: EHA-ESMO Clinical Practice Guidelines for Diagnosis, Treatment and Follow-up
por: Meletios A. Dimopoulos, et al.
Publicado: (2021) -
INSIGHTS INTO DIAGNOSIS AND MANAGEMENT OF ADVANCED MULTIPLE MYELOMA
por: Vasile Musteata, et al.
Publicado: (2021) -
CASE REPORT: COEXISTENCE OF CELIAC DISEASE AND MULTIPLE MYELOMA
por: Filiz YAVASOGLU, et al.
Publicado: (2021)